Results 101 to 110 of about 55,779 (204)

Severe dengue hemorrhagic fever after TAK-003 dengue vaccination: A case report of a potential vaccine-associated adverse reaction

International Journal of Infectious Diseases
We report a severe dengue case that developed symptoms 5 days post-TAK-003 dengue vaccine administration. Whole-genome sequencing confirmed co-detection of all four dengue serotypes with high similarity to vaccine strains, especially DENV-2. This finding
Pinyo Rattanaumpawan, Navin Horthongkham, Kamol Suwannakarn, Artittaya Athipanyasilp, Ubonvan Jongwutiwes   +4 more
doaj   +1 more source

Dengue vaccines: A new hope? [PDF]

Human Vaccines, 2009
Dengue infection is an important arboviral infection that has become a public health concern. Dengue vaccination is the expected primary prevention for this infection. However, dengue vaccine is not presently available. In this article, the author discusses and comments on the problem, hope and present status in dengue vaccine development.
openaire   +2 more sources

Designing of a multiepitope-based chimeric vaccine against dengue virus serotype 3 (DENV-3) through next generation reverse vaccinology approaches

Informatics in Medicine Unlocked
The dengue virus (DENV) causes dengue infection and has become a significant global public health concern. The successful application of immunotherapies in treating dengue infection has paved the way for developing various treatment strategies.
Md Habib Ullah Masum, Jannatul Ferdous, Syed Lokman, Amam Zonaed Siddiki   +3 more
doaj   +1 more source

Complexity of Human Antibody Response to Dengue Virus: Implication for Vaccine Development

Frontiers in Microbiology, 2017
The four serotypes of dengue virus (DENV) are the leading cause of arboviral diseases in humans. Decades of efforts have made remarkable progress in dengue vaccine development.
Wen-Yang Tsai, Hong-En Lin, Wei-Kung Wang   +2 more
doaj   +1 more source

[Dengue treatments and vaccines].

Medecine sciences : M/S
La dengue est une maladie virale transmise par les moustiques du genre Aedes, dont l’incidence et l’aire de répartition sont en constante augmentation depuis les dernières décennies. Causant des fièvres hémorragiques dans les cas graves, elle touche principalement les zones tropicales et subtropicales du globe, et menace de s’étendre à de nouvelles ...
Brézillon-Dubus, Lazare, Dupuis, Benjamin, Failloux, Anna-Bella   +2 more
openaire   +2 more sources

Analysis of the evidence on the efficacy and safety of CYD-TDV dengue vaccine and its potential licensing and implementation through Mexico´s Universal Vaccination Program

Salud Pública de México, 2016
Dengue is a major global public health problem affecting Latin America and Mexico Prevention and control measures, focusing on epidemiological surveillance and vector control, have been partially effective and costly, thus, the development of a vaccine ...
Mauricio Hernández-Ávila, José Ignacio Santos-Preciado   +1 more
doaj  

Proceedings of the inaugural symposium on dengue human challenge studies "Challenging the norm: Accelerating dengue countermeasures through human studies".

PLoS Neglected Tropical Diseases
On 12th June 2025, Duke-NUS Medical School, supported by the Global Dengue and Aedes-Transmitted Diseases Consortium (GDAC), hosted a one-day symposium in Singapore titled "Challenging the norm: Accelerating dengue countermeasures through human challenge
Shirin Kalimuddin, Adam T Waickman, Panisadee Avirutnan, Mohammad Shafiul Alam, Christopher Chiu, Barnaby E Young, Christopher W Woods, Petra C Fay, Sheila K Pakir, Jo-Anne Manski-Nankervis, Claus Bolte, Andrew Pengilley, Marco Cavaleri, John C W Lim, Stephen J Thomas, Albert I Ko, Eng Eong Ooi   +16 more
doaj   +1 more source

Dengue and Dengue Vaccines [PDF]

The Journal of Infectious Diseases, 2005
openaire   +1 more source

Dengue vaccine endgame: why has the global response to exponential demand in the tropics been so slow?

Frontiers in Tropical Diseases
IntroductionThere has been a dramatic global surge in dengue fever (DF) in recent years, with a projected 100-400 million cases annually and large outbreaks expected every 3-4 years.
Cristina Possas, Ernesto T. A. Marques, Ernesto T. A. Marques, Alessandra Oliveira, Suzanne Schumacher, Adelaide Antunes, Adelaide Antunes, Akira Homma   +7 more
doaj   +1 more source

Safety of Dengue Vaccine? [PDF]

Clin Infect Dis, 2023
Biswal S, Patel SS, Rauscher M.
europepmc   +2 more sources